RAD-150 (TLB-150), (10mg/capsule) 60 Capsules
Original price was: $114.00.$89.95Current price is: $89.95.
RAD-150 (TLB-150) is a benzoate ester derivative of RAD-140 (Testolone) designed as a prodrug that undergoes ester hydrolysis to release RAD-140 as the active androgen receptor (AR) agonist. The addition of the benzoate ester modifies the physicochemical properties of the parent molecule, making RAD-150 a useful… CAS: 1208070-53-4 | Formula: C27H20ClN5O3 | Content: 600 mg (10 mg per capsule) | Research use only | Third-party lab tested.
Buy RAD-150 (TLB-150), (10mg/capsule) 60 Capsules – Swiss Chems USA
RAD-150 (TLB-150), (10mg/capsule) 60 Capsules — Research Overview
RAD-150 (TLB-150) is a benzoate ester derivative of RAD-140 (Testolone) designed as a prodrug that undergoes ester hydrolysis to release RAD-140 as the active androgen receptor (AR) agonist. The addition of the benzoate ester modifies the physicochemical properties of the parent molecule, making RAD-150 a useful research tool for investigating prodrug design strategies, esterification chemistry, and metabolic conversion mechanisms. Experimental studies have examined its interactions with AR-mediated signaling pathways, ligand-receptor binding dynamics, and receptor-associated transcriptional regulation following conversion to the active species. Research applications include prodrug pharmacology, ester hydrolysis studies, androgen receptor signaling investigation, structure-activity relationship analysis, and mechanistic evaluation of esterified androgen receptor modulators.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
RAD-150 (TLB-150), (10mg/capsule) 60 Capsules Chemical Properties
| Property | Specification |
|---|---|
| Chemical Formula | C27H20ClN5O3 |
| Synonyms | TLB-150 Benzoate, RAD-140 Benzoate ester |
| Molar Mass | 497.93 g/mol |
| CAS Number | 1208070-53-4 |
| PubChem CID | 68547459 |
| Total Compound Content | 600 mg (10 mg per capsule) |
| Shelf Life | 36 months |
RAD-150 (TLB-150), (10mg/capsule) 60 Capsules Research Applications
RAD-150 (TLB-150 Benzoate) is a benzoate ester derivative of RAD-140 (Testolone) designed as a prodrug that undergoes ester hydrolysis to release RAD-140 as the active androgen receptor (AR) agonist. The addition of the benzoate ester modifies the physicochemical and metabolic characteristics of the parent molecule, making RAD-150 a useful research tool for investigating prodrug design strategies, esterification chemistry, and metabolic conversion mechanisms. Following conversion, the released RAD-140 retains its characteristic AR-binding and receptor-mediated signaling profile. Research applications include prodrug pharmacology, ester hydrolysis studies, androgen receptor signaling investigation, controlled-release compound design, and comparative structure-activity relationship analysis of esterified androgen receptor modulators. Supplied in 10 mg capsules. Independently third-party HPLC-tested; COA available per batch.
RAD-150 (TLB-150), (10mg/capsule) 60 Capsules Frequently Asked Questions
What is the rationale for esterifying RAD-140 to produce RAD-150?
RAD-150 incorporates a benzoate ester modification of the RAD-140 scaffold, creating a prodrug designed for metabolic conversion to the parent compound. This esterification alters the physicochemical and metabolic characteristics of the molecule, making RAD-150 a useful research tool for investigating prodrug design strategies, ester hydrolysis mechanisms, and the impact of structural modification on compound disposition. Such approaches are commonly used in medicinal chemistry to examine how ester derivatives influence the behavior of parent compounds.
Is RAD-150 itself pharmacologically active, or does it require conversion to RAD-140?
RAD-150 functions primarily as a prodrug that undergoes ester hydrolysis to release RAD-140. The conversion process is central to its research utility, allowing investigators to examine metabolic activation pathways, prodrug pharmacology, and the relationship between esterified compounds and their active metabolites. Following hydrolysis, the released RAD-140 retains its characteristic androgen receptor interaction profile, making RAD-150 a valuable tool for studies of compound conversion and receptor-mediated signaling.
What distinguishes RAD-150 from other SARMs in pharmacology research?
RAD-150 is distinguished by its esterified prodrug design, whereas most SARMs are investigated in their active, non-esterified forms. This characteristic makes RAD-150 useful for studies examining esterification chemistry, metabolic conversion mechanisms, structure-activity relationships, and comparative pharmacology between parent compounds and ester derivatives. Its design provides a distinct model for investigating how chemical modification influences the properties of androgen receptor modulators.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
| Weight | 3 lbs |
|---|
Reviews
There are no reviews yet.